Published in Surg Endosc on September 16, 2010
Laparoscopic versus open resection of colorectal liver metastasis. Surg Endosc (2012) 0.98
Value of radiofrequency ablation in the treatment of hepatocellular carcinoma. World J Gastroenterol (2014) 0.87
Initial experience with a new articulating energy device for laparoscopic liver resection. Surg Endosc (2014) 0.80
Laparoscopic treatment of liver tumours using a two-needle probe bipolar radiofrequency ablation device. HPB (Oxford) (2011) 0.77
Appraisal of Laparoscopic Liver Resection in the Treatment of Liver Metastasis with Special Reference to Outcome in Colorectal Malignancies. Indian J Surg (2013) 0.75
The Feasibility of Hepatic Resections Using a Bipolar Radiofrequency Device (Habib®). Indian J Surg (2015) 0.75
HabibTM 4X-assisted resection versus clamp-crush resection for hepatocellular carcinoma: a propensity-matching study. Oncotarget (2016) 0.75
Intratumoral coagulation by radiofrequency ablation facilitated the laparoscopic resection of giant hepatic hemangioma: a surgical technique report of two cases. Oncotarget (2017) 0.75
Precoagulation-assisted parenchyma-sparing laparoscopic liver surgery: rationale and surgical technique. Surg Endosc (2016) 0.75
Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg (2002) 8.30
Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg (2003) 3.14
New technique for liver resection using heat coagulative necrosis. Ann Surg (2002) 3.13
Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg (1998) 2.97
Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg (1997) 2.83
Portal triad clamping or hepatic vascular exclusion for major liver resection. A controlled study. Ann Surg (1996) 2.35
Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg (2009) 1.94
Negative impact of blood transfusion on recurrence and prognosis of hepatocellular carcinoma after hepatic resection. J Gastrointest Surg (2009) 1.69
Ultrasound-guided radiofrequency-assisted segmental liver resection: a new technique. Ann Surg (2009) 1.60
Morbidity and mortality after liver resection: results of the patient safety in surgery study. J Am Coll Surg (2007) 1.45
Bloodless liver resection using radiofrequency energy. Dig Surg (2007) 1.12
Resection of hepatocellular carcinoma: the effect of surgical margin and blood transfusion on long-term survival. Analysis of 209 consecutive patients. Hepatogastroenterology (2007) 0.92
Perioperative blood transfusion and survival following curative hepatic resection for hepatocellular carcinoma. Hepatogastroenterology (2005) 0.92
Laparoscopic liver resection assisted with radiofrequency. Am J Surg (2007) 0.90
Radiofrequency ablation-assisted liver resection: review of the literature and our experience. HPB (Oxford) (2006) 0.88
Liver resection with a new multiprobe bipolar radiofrequency device. Arch Surg (2008) 0.85
Radiofrequency-assisted liver resection in cirrhotic patients with hepatocellular carcinoma. J Surg Oncol (2008) 0.85
Precoagulation minimizes blood loss during standardized hepatic resection in an experimental model. Br J Surg (2005) 0.83
A multicentre controlled study of the InLine radiofrequency ablation device for liver transection. HPB (Oxford) (2007) 0.79
Laparoscopic liver resection assisted by the laparoscopic Habib Sealer. Surgery (2008) 0.78
Virtually bloodless laparoscopic liver resection of recurrent hepatoma with a new laparoscopic sealer device: report of our initial laparoscopic experience. Surg Laparosc Endosc Percutan Tech (2007) 0.77
Use of radiofrequency hepatic parenchymal transection device in hepatic hemangioma resection: early experience and lessons learned. HPB (Oxford) (2007) 0.77
Liver resection using a four-prong radiofrequency transection device. Am Surg (2009) 0.77
Microwave energy as a precoagulative device to assist in hepatic resection. Ann Surg Oncol (2009) 0.77
Liver resection using heat coagulative necrosis: indications and limits of a new method. ANZ J Surg (2009) 0.75
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl (2012) 4.65
Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease. Liver Int (2011) 2.85
Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience. Ann Surg (2007) 2.28
Screening for thyroid cancer in patients with familial adenomatous polyposis. Ann Surg (2011) 2.21
What is the indication for sorafenib in hepatocellular carcinoma? A clinical challenge. Oncology (Williston Park) (2011) 2.12
Open letter to Xi Jinping, President of the People's Republic of China: China's fight against corruption in organ transplantation. Transplantation (2014) 2.11
Safety and efficacy of splenic artery embolization for portal hyperperfusion in liver transplant recipients: a 5-year experience. Liver Transpl (2015) 2.03
Adjuvant treatment after orthotopic liver transplantation: is it really necessary? Oncology (Williston Park) (2009) 2.02
Near-total human face transplantation for a severely disfigured patient in the USA. Lancet (2009) 1.97
The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation. Liver Transpl (2008) 1.75
First U.S. near-total human face transplantation: a paradigm shift for massive complex injuries. Plast Reconstr Surg (2010) 1.70
Predicting the success of limited exploration for primary hyperparathyroidism using ultrasound, sestamibi, and intraoperative parathyroid hormone: analysis of 1158 cases. Ann Surg (2008) 1.70
The prognostic value of the neutrophil-lymphocyte ratio (NLR) in acute pancreatitis: identification of an optimal NLR. J Gastrointest Surg (2013) 1.70
Subxiphoid incisional hernias after median sternotomy. J Am Coll Surg (2005) 1.67
Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma. J Surg Oncol (2008) 1.64
Recurrent hepatitis C after liver transplantation: on-treatment prediction of response to peginterferon/ribavirin therapy. Liver Transpl (2008) 1.61
A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease. Mol Genet Metab (2007) 1.61
Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant (2003) 1.58
Tobacco use following liver transplantation for alcoholic liver disease: an underestimated problem. Liver Transpl (2005) 1.55
Robotic vs laparoscopic posterior retroperitoneal adrenalectomy. Arch Surg (2012) 1.54
The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record. Surgery (2013) 1.53
Pseudallescheria boydii (Anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature. Medicine (Baltimore) (2002) 1.53
Influenza virus infection in adult solid organ transplant recipients. Am J Transplant (2002) 1.52
Side-to-side cavocavostomy with an endovascular stapler: Rescue technique for severe hepatic vein and/or inferior vena cava outflow obstruction after liver transplantation using the piggyback technique. Liver Transpl (2009) 1.51
Safety and effectiveness of renoportal bypass in patients with complete portal vein thrombosis: an analysis of 10 patients. Liver Transpl (2015) 1.49
Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival. Surgery (2007) 1.48
The phenotype of primary hyperparathyroidism with normal parathyroid hormone levels: how low can parathyroid hormone go? Surgery (2011) 1.48
Internal jugular vein thrombosis in a warfarinised patient: a case report. J Med Case Rep (2007) 1.46
The endocrine surgery job market: a survey of fellows, department chairs, and surgery recruiters. J Surg Educ (2013) 1.46
Correlation between postoperative infective complications and long-term outcomes after hepatic resection for colorectal liver metastasis. Ann Surg (2010) 1.45
A new, vitamin D-based, multidimensional nomogram for the diagnosis of primary hyperparathyroidism. Endocr Pract (2012) 1.44
The use of the harmonic scalpel vs conventional knot tying for vessel ligation in thyroid surgery. Arch Surg (2002) 1.44
Impact of localization studies and clinical scenario in patients with hyperparathyroidism being evaluated for reoperative neck surgery. Arch Surg (2011) 1.41
Increased prevalence of breast cancer among patients with thyroid and parathyroid disease. Surgery (2007) 1.41
Emergency presentation of abdominal hernias: outcome and reasons for delay in treatment - a prospective study. Ann R Coll Surg Engl (2007) 1.34
Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases. J Hepatobiliary Pancreat Surg (2008) 1.30
Robotic versus laparoscopic resection of liver tumours. HPB (Oxford) (2010) 1.25
Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology (2006) 1.24
Comparison of laparoscopic versus open liver tumor resection: a case-controlled study. Surg Endosc (2008) 1.24
Cryptococcosis in organ transplant recipients: an overview. Am J Transplant (2002) 1.21
Hepatic stellate cells preferentially expand allogeneic CD4+ CD25+ FoxP3+ regulatory T cells in an IL-2-dependent manner. Transplantation (2008) 1.20
Pancreatic lesions in von Hippel-Lindau disease? A systematic review and meta-synthesis of the literature. J Gastrointest Surg (2012) 1.17
Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg (2002) 1.16
Laparoscopic vs open pancreaticoduodenectomy. J Am Coll Surg (2013) 1.15
MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates. Gastroenterology (2009) 1.11
The changing presentation of hyperparathyroidism over 3 decades. Arch Surg (2008) 1.07
Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors. Acta Oncol (2012) 1.06
Laparoscopic resection of abdominal paragangliomas. Surg Laparosc Endosc Percutan Tech (2011) 1.06
Circulating thyrotropin receptor mRNA as a novel marker of thyroid cancer: clinical applications learned from 1758 samples. Ann Surg (2010) 1.06
Laparoscopic versus open ventral hernia repairs: 5 year recurrence rates. Surg Endosc (2008) 1.05
Laparoscopic radiofrequency thermal ablation of neuroendocrine hepatic metastases: long-term follow-up. Surgery (2010) 1.05
Prospective evaluation of sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidism. Surgery (2004) 1.05
Robotic versus laparoscopic adrenalectomy for pheochromocytoma. Ann Surg Oncol (2013) 1.04
Comparison of intraoperative time use and perioperative outcomes for robotic versus laparoscopic adrenalectomy. Surgery (2011) 1.04
New paradigm in the management of liver-only metastases from colorectal cancer. Gastrointest Cancer Res (2007) 1.03
Sclerosing Angiomatoid Nodular Transformation (SANT) of the spleen: Case report and review of the literature. Int J Surg Case Rep (2012) 1.02
Diagnostic accuracy of surgeon-performed ultrasound-guided fine-needle aspiration of thyroid nodules. Ann Surg Oncol (2011) 1.00
Incentives for organ donation: proposed standards for an internationally acceptable system. Am J Transplant (2011) 0.99
Surgical technique and systemic inflammation influences long-term disease-free survival following hepatic resection for colorectal metastasis. J Surg Oncol (2008) 0.99
National trends in parathyroid surgery from 1998 to 2008: a decade of change. J Am Coll Surg (2009) 0.99
Laparoscopic versus open resection of colorectal liver metastasis. Surg Endosc (2012) 0.98
Initial experience using histidine-tryptophan-ketoglutarate solution in clinical pancreas transplantation. Clin Transplant (2004) 0.98
Intestinal transplantation: a coming of age. Adv Surg (2002) 0.98
Robotic transaxillary endocrine surgery: a comparison with conventional open technique. Surg Endosc (2012) 0.96
Ultrasonography for the endocrine surgeon: a valuable clinical tool that enhances diagnostic and therapeutic outcomes. Surgery (2005) 0.95
Pediatric liver transplantation. A single center experience spanning 20 years. Transplantation (2002) 0.95
Adenoid cystic carcinoma of the base of the tongue: Late metastasis to the pancreas. Int J Surg Case Rep (2010) 0.94
Should patients with Cowden syndrome undergo prophylactic thyroidectomy? Surgery (2012) 0.93
Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation. Clin Transplant (2010) 0.93
Results of pancreatic surgery in the elderly: is age a barrier? HPB (Oxford) (2012) 0.93
Combined liver-kidney transplants: allosensitization and recipient outcomes. Transplantation (2011) 0.92
Robotic versus laparoscopic adrenalectomy in obese patients. Surg Endosc (2012) 0.91
Safety and efficacy of sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation. Clin Transplant (2013) 0.91
Change in adrenal mass size as a predictor of a malignant tumor. Endocr Pract (2010) 0.91
Safety and feasibility of using sorafenib in recurrent hepatocellular carcinoma after orthotopic liver transplantation. Oncology (2010) 0.91
The impact of office neck ultrasonography on reducing unnecessary thyroid surgery in patients undergoing parathyroidectomy. Thyroid (2005) 0.91
Pre-operative prediction of pancreatic fistula: is it possible? Pancreatology (2013) 0.91
Radiologic complete response with sirolimus and sorafenib in a hepatocellular carcinoma patient who relapsed after orthotopic liver transplantation. J Gastrointest Cancer (2011) 0.90
Fibroblast growth factor 21 as a biomarker for NAFLD: integrating pathobiology into clinical practice. J Hepatol (2010) 0.90
Value of intraoperative parathyroid hormone monitoring. Ann Surg Oncol (2007) 0.89
"Splenic artery steal syndrome" is a misnomer: the cause is portal hyperperfusion, not arterial siphon. Liver Transpl (2008) 0.89
De novo breast cancer in patients with liver transplantation: University of Pittsburgh's experience and review of the literature. Liver Transpl (2004) 0.89
Post-liver transplantation sarcopenia in cirrhosis: a prospective evaluation. J Gastroenterol Hepatol (2014) 0.89
Incidence of de novo cancer and lymphoproliferative disorders after liver transplantation in relation to age and duration of follow-up. Liver Transpl (2008) 0.88
Metabonomics: a useful tool for the future surgeon. J Surg Res (2009) 0.88
Myeloid suppressor cells induced by retinal pigment epithelial cells inhibit autoreactive T-cell responses that lead to experimental autoimmune uveitis. Invest Ophthalmol Vis Sci (2012) 0.88
Interaction of tumour biology and tumour burden in determining outcome after hepatic resection for colorectal metastases. HPB (Oxford) (2010) 0.88
Transcriptional profile of genes involved in oxidative stress and antioxidant defense in a dietary murine model of steatohepatitis. Antioxid Redox Signal (2011) 0.88
Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer. Ann Surg Oncol (2008) 0.87
Robotic versus laparoscopic resection of large adrenal tumors. Ann Surg Oncol (2012) 0.87
Avoidable reoperations for thyroid and parathyroid surgery: effect of hospital volume. Surgery (2008) 0.87
Vascular endothelial growth factor receptor 2 expression in non-tumorous cirrhotic liver is higher when hepatoma is beyond Milan criteria. Liver Transpl (2009) 0.87
Inflammatory response related scoring systems in assessing the prognosis of patients with pancreatic ductal adenocarcinoma: a systematic review. Hepatobiliary Pancreat Dis Int (2014) 0.87